Jonkman, Laura E.
Kenkhuis, Boyd
Geurts, Jeroen J. G.
van de Berg, Wilma D. J.
Article History
Received: 27 June 2018
Accepted: 29 October 2018
First Online: 21 February 2019
Conflict of interest
: L. E. Jonkman is financially supported by a grant from the Alzheimer’s Association (AARF-18-566459). B. Kenkhuis has no conflict of interest. J. J. G. Geurts is an editor of MS Journal. He serves on the editorial boards of Neurology and Frontiers of Neurology and is President of the Netherlands Organization for Health Research and Innovation. He has served as a consultant for Merck-Serono, Biogen, Novartis, Genzyme, and Teva Pharmaceuticals. W. D. J. van de Berg is financially supported by grants from Amsterdam Neuroscience, ZonMW Memorabel, ZonMW Technology Hotel, Stichting Parkinson Fonds, Alzheimer Netherlands-LECMA, Roche Pharma, Lysosomal Therapeutics, and Cross-beta Sciences. She is a consultant for CHDR Leiden and Lysosomal Therapeutics.